Crohn Disease
Conditions
Brief summary
Observational, prospective, single-center follow-up study carried out with patients from the area of the Virgen de Macarena University Hospital, diagnosed with chronic kidney disease, who started treatment with ustekinumab.
Detailed description
Prospective follow-up observational study carried out with patients from the Virgen de Macarena University Hospital, under treatment with ustekinumab in the induction and maintenance phase in order to determine the cut-off points of the ustekinumab levels between which a clinical remission is expected in patients with inflammatory bowel disease.
Interventions
None listed
Sponsors
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Over 18 years. * Patients treated with ustekinumab in induction and maintenance phase. * They must agree to participate in the clinical study, having previously signed the informed consent.
Exclusion criteria
* Any patient who does not meet the inclusion criteria previously described and / or who refuses to participate in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Determine breakpoints. | Up to 44 weeks. | To determine the breakpoints for ustekinumab levels between which clinical remission is expected in patients with inflammatory bowel disease. |
Countries
Spain
Contacts
Primary ContactFederico Arguelles Arias
Backup ContactCarlos García Pérez
Outcome results
None listed